Placebo controlled trial of bosentan vs placebo in NYHA class I/II sclerodoma patients with exercise induced pulmonary hypertension.
Phase of Trial: Phase II
Latest Information Update: 29 May 2018
At a glance
- Drugs Bosentan (Primary)
- Indications Exercise-induced hypertension
- Focus Pharmacodynamics
- 10 Jun 2017 Biomarkers information updated
- 19 Jul 2011 Status changed from suspended to discontinued as reported by ClinicalTrials.gov.
- 14 Jul 2010 Status changed from recruiting to suspended as reported by ClinicalTrials.gov.